Implantation and preliminary follow-up of the Bard Valeo stent in pulmonary artery stenosis.

Catheter Cardiovasc Interv

East Midlands Congenital Heart Centre, Glenfield Hospital, Groby Road, Leicester, LE3 9QP, United Kingdom.

Published: August 2014

AI Article Synopsis

Article Abstract

Objectives: To evaluate the performance of the Bard Valeo stent in pulmonary artery stenoses.

Background: The premounted Valeo stent requires only 6-7 French access and can be post-dilated to 20 mm on bench testing. Although it appears ideal for implantation in pulmonary artery stenoses in children, it has been unclear whether it has sufficient radial strength to prevent vessel recoil and stent collapse.

Methods: Twelve stents were implanted in 10 patients aged 1.2-19.9 years (weight 9.9-54 kg). Implant results were assessed retrospectively.

Results: All implants were successful with no complications. The stent tracked easily and was readily visible on fluoroscopy. The median (range) diameter of the pulmonary artery stenosis increased from 4.9 (1.8-7.4) mm to 9 (6-10.6) mm (P ≤ 0.01), the median peak to peak systolic pressure gradient across the pulmonary artery stenosis decreased from 16 (11-66) mmHg to 6 (0-10) mmHg (P ≤ 0.01), and the right ventricle to systemic blood pressure ratio fell from 0.72 (0.54-1.1) to 0.54 (0.28-0.69) (P ≤ 0.01). Median stent recoil was 5.5 (0-21)%. Jailed side branches remained patent. Nine stents were assessed fluoroscopically on 11.5 (0-30) month follow-up. There were no stent fractures. 6 stents were not distorted, 2 had minor distortion, and 1 stent, implanted in a highly resistant lesion, had moderate distortion.

Conclusions: The Valeo stent is low profile, conformable, and easy to deliver, even in small children. It has adequate radial strength to stent pulmonary artery stenoses with minimal recoil. It maintains its geometry on medium term follow up in compliant lesions. Resistant stenoses may distort the stent.

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.25443DOI Listing

Publication Analysis

Top Keywords

pulmonary artery
24
valeo stent
16
stent pulmonary
12
artery stenosis
12
stent
11
bard valeo
8
artery stenoses
8
radial strength
8
p ≤ 001 median
8
pulmonary
6

Similar Publications

Atypical pulmonary manifestations suggestive of lung cancer in behçet's disease with spontaneously regressing lymphadenopathy and a lung mass: a case report.

BMC Pulm Med

January 2025

Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, 301-721, Republic of Korea.

Background: Behçet's disease (BD) is a multisystem inflammatory disorder that can affect various organs, including the lungs. Pulmonary manifestations are rare and typically present as pulmonary artery aneurysms.

Case Presentation: We report the case of a 56-year-old East Asian male with a 27-year history of BD, who had no respiratory symptoms, such as hemoptysis, cough, or fever.

View Article and Find Full Text PDF

Background: The binding of endothelin-1 (ET-1) to endothelin type A receptor (ETAR) performs a critical action in pulmonary arterial smooth muscle cell (PASMC) proliferation leading to pulmonary vascular structural remodeling. More evidence showed that cystathionine γ-lyase (CSE)-catalyzed endogenous hydrogen sulfide (HS) was involved in the pathogenesis of cardiovascular diseases. In this study, we aimed to explore the effect of endogenous HS/CSE pathway on the ET-1/ETAR binding and its underlying mechanisms in the cellular and animal models of PASMC proliferation.

View Article and Find Full Text PDF

Hypoxia Combined With Interleukin-17 Regulates Hypoxia-Inducible Factor-1α/Endothelial Nitric Oxide Synthase Expression in Pulmonary Artery Endothelial Cells.

J Cell Mol Med

January 2025

Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.

The pathogenesis of chronic thromboembolic pulmonary hypertension may be multifactorial and requires further studies. We explored alterations in pulmonary artery endothelial cells under the hypoxic and elevated interleukin-17 conditions that are commonly present in patients with chronic thromboembolic pulmonary hypertension. We measured the serum interleukin-17 levels in 10 chronic thromboembolic pulmonary hypertension patients and 10 healthy control persons.

View Article and Find Full Text PDF

Negative Pressure Ventilation Ex-Situ Lung Perfusion Preserves Porcine and Human Lungs for 36-Hours.

Clin Transplant

January 2025

Division of Cardiac Surgery, Department of Surgery, Faculty of Medicine, University of Alberta, Edmonton, Canada.

Introduction: Preclinically, 24-hour continuous Ex-Situ Lung Perfusion (ESLP) is the longest duration achieved in large animal models and rejected human lungs. Here, we present our 36-hour Negative Pressure Ventilation (NPV)-ESLP protocol applied to porcine and rejected human lungs.

Methods: Five sets of donor domestic pig lungs (45-55 kg) underwent 36-hour NPV-ESLP.

View Article and Find Full Text PDF

Background: Atrial fibrillation (AF) is a prevalent cardiac arrhythmia, with ventricular rate control being a critical therapeutic target. However, the optimal range for ventricular rate control remains unclear. Additionally, the relationship between different levels of ventricular rate control and cardiac remodeling in patients with atrial fibrillation remains unclear.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!